Add-on angiotensin receptor blockade with maximized ACE inhibition
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 59 (6), 2282-2289
- https://doi.org/10.1046/j.1523-1755.2001.00745.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal FailureNew England Journal of Medicine, 1999
- ACE (I/D) Genotype as a Predictor of the Magnitude and Duration of the Response to an ACE Inhibitor Drug (Enalaprilat) in HumansCirculation, 1998
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyThe Lancet, 1997
- The Role of Genetic Polymorphisms of Angiotensin-Converting Enzyme in the Progression of Renal DiseasesHypertension, 1996
- Angiotensin Receptors and Their AntagonistsNew England Journal of Medicine, 1996
- Blood Pressure Control, Proteinuria, and the Progression of Renal DiseaseAnnals of Internal Medicine, 1995
- Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.Journal of Clinical Investigation, 1995
- Enhanced Pressor Response to Angiotensin I in Normotensive Men With the Deletion Genotype (DD) for Angiotensin-Converting EnzymeHypertension, 1995
- The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal DiseaseNew England Journal of Medicine, 1994
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990